Biomaterials in Medicine/Drug Formation
Biomaterials play a vital role in delivery systems mainly in drug delivery. The design of various drug delivery systems, surgical implants, wound closure devices, artificial organs are mostly depends on the biomaterials.Biomaterials help in gene delivery that ultimately induce transgene expression and tissue growth along with regeneration of tissues. By Immunomodulation i.e, modulating or changing the various aspects of immune system, the potency and efficiency of regenerative medicine therapies can be increased. Nowadays, hydrogels are termed as the smart drug delivery system; they are mostly used as sustained drug release systems, which have importance in treatment of cancer. Extracellular media or vesicles are used for the macromolecular drug delivery. Biomaterials can also be used for islet delivery, for imaging, etc.
- For islet delivery
- In gene therapy
- Polymeric hydrogels for drug deliver
Related Conference of Biomaterials in Medicine/Drug Formation
18th International Conference on Human Genomics and Genomic Medicine
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Biomaterials in Medicine/Drug Formation Conference Speakers
Recommended Sessions
- Biomaterials and Biopolymers
- Naturally Derived Biomaterials
- Polymer Synthesis and Innovations
- Advanced Biomaterials
- Advances in 3D printing of Biomaterials
- Advances in Regenerative Technologies
- Bio fluid Mechanics
- Bio hybrid Artificial Organs
- Bio photonics
- Biocompatibility of Nanomaterial – Cellular Signalling
- Biodegradable Biomaterials
- Biomaterials in Medicine/Drug Formation
- Biomimetic Chemistry and Synthetic Biology
- Cybergenetics
- Gene Editing
- Synthetic Gene Networks
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)

